208 related articles for article (PubMed ID: 7808738)
1. [Hypocholesterolemia and other lipoprotein disorders in myelofibrosis].
Kiss A; Telek B; Rák K
Orv Hetil; 1994 Nov; 135(48):2643-6. PubMed ID: 7808738
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein composition in agnogenic myeloid metaplasia.
Léglise D; Abgrall JF; Desfontaine B; Dutel JL; Bardou LG; Brière J
Biomed Pharmacother; 1985; 39(3):135-9. PubMed ID: 4063464
[TBL] [Abstract][Full Text] [Related]
3. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
4. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
Hasselbalch H; Clemmensen I
Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
[TBL] [Abstract][Full Text] [Related]
5. Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity.
Gilbert HS; Ginsberg H; Fagerstrom R; Brown WV
Am J Med; 1981 Oct; 71(4):595-602. PubMed ID: 7282748
[TBL] [Abstract][Full Text] [Related]
6. [Chronic myeloid leukemia with progression to polycythemia vera].
Campo MC; Fortún A; Travieso J
Sangre (Barc); 1992 Jun; 37(3):207-8. PubMed ID: 1440100
[No Abstract] [Full Text] [Related]
7. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
8. Hypocholesterolemia in myeloproliferative disorders.
Spanos GA; Bajaj K; Rosner F
Arch Intern Med; 1981 Jan; 141(1):137-8. PubMed ID: 6934710
[No Abstract] [Full Text] [Related]
9. [Results of selected cytochemical studies of mature granulocytes in myelodysplastic syndromes and various other hematologic diseases].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):54-7. PubMed ID: 1823968
[TBL] [Abstract][Full Text] [Related]
10. Endomitotic index of megakaryocytes measured by flow cytometry helps to diagnose hematological disorders with abnormal platelet counts.
Baatout S; Chatelain B; Staquet P; Symann M; Chatelain C
Anticancer Res; 1998; 18(5A):3347-53. PubMed ID: 9858907
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
12. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
13. Prognostic parameters in myeloid metaplasia: agnogenic versus postpolycythemic.
Meytes D; Katz D; Ramot B
Isr J Med Sci; 1976 Jun; 12(6):534-42. PubMed ID: 955869
[TBL] [Abstract][Full Text] [Related]
14. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
15. Serum cholesterol and triglycerides in hematological malignancies.
Marini A; Carulli G; Azzarà A; Grassi B; Ambrogi F
Acta Haematol; 1989; 81(2):75-9. PubMed ID: 2496554
[TBL] [Abstract][Full Text] [Related]
16. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
17. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
[TBL] [Abstract][Full Text] [Related]
18. Serum cholesterol and apoprotein B levels and serum cholinesterase activity in selected hematologic malignancies.
Cucuianu A; Malide D; Petrov L; Patiu M; Vlaicu S; Cucuianu M
Rom J Intern Med; 1992; 30(4):261-8. PubMed ID: 1299417
[TBL] [Abstract][Full Text] [Related]
19. Myelosclerosis: a study of a condition also known as myelofibrosis, aleuchaemic myelosis, agnogenic myeloid metaplasia, and other titles.
ROBSON HN
Australas Ann Med; 1953 Nov; 2(2):170-8. PubMed ID: 13115298
[No Abstract] [Full Text] [Related]
20. Neutrophil 5-nucleotidase reaction in chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, and polycythemia vera.
Tsavaris NB; Pangalis GA
Ann Hematol; 1998 Jan; 76(1):1-5. PubMed ID: 9486917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
